Publication: Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: A prospective cohort study
Issued Date
2014-01-01
Resource Type
ISSN
14219735
02535068
02535068
Other identifier(s)
2-s2.0-84929654830
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Blood Purification. Vol.38, No.3-4 (2014), 253-262
Suggested Citation
Thanachai Panaput, Bandit Thinkhamrop, Somnuek Domrongkitchaiporn, Dhavee Sirivongs, Laksamon Praderm, Jirasak Anukulanantachai, Chavasak Kanokkantapong, Pakorn Tungkasereerak, Cholatip Pongskul, Sirirat Anutrakulchai, Thathsalang Keobounma, Surapong Narenpitak, Pisith Intarawongchot, Ammrit Suwattanasin, Sajja Tatiyanupanwong, Kannika Niwattayakul Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: A prospective cohort study. Blood Purification. Vol.38, No.3-4 (2014), 253-262. doi:10.1159/000368885 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/34861
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: A prospective cohort study
Author(s)
Thanachai Panaput
Bandit Thinkhamrop
Somnuek Domrongkitchaiporn
Dhavee Sirivongs
Laksamon Praderm
Jirasak Anukulanantachai
Chavasak Kanokkantapong
Pakorn Tungkasereerak
Cholatip Pongskul
Sirirat Anutrakulchai
Thathsalang Keobounma
Surapong Narenpitak
Pisith Intarawongchot
Ammrit Suwattanasin
Sajja Tatiyanupanwong
Kannika Niwattayakul
Bandit Thinkhamrop
Somnuek Domrongkitchaiporn
Dhavee Sirivongs
Laksamon Praderm
Jirasak Anukulanantachai
Chavasak Kanokkantapong
Pakorn Tungkasereerak
Cholatip Pongskul
Sirirat Anutrakulchai
Thathsalang Keobounma
Surapong Narenpitak
Pisith Intarawongchot
Ammrit Suwattanasin
Sajja Tatiyanupanwong
Kannika Niwattayakul
Abstract
© 2015 S. Karger AG, Basel. Background/Aims: We aimed to define the dosing and risk factors for death in patients undergoing twice-weekly hemodialysis. Methods: A prospective multi-center cohort study was conducted with one-year observation. Patients treated with twice- or thrice-weekly hemodialysis were identified. Death and first admission were the outcomes. spKt/V was a factor of interest. Results: We enrolled 504 twice-weekly and 169 thrice-weekly hemodialysis patients. The mean weekly values of spKt/V in the two groups were 3.4 and 5.1. The one-year survival rate and times to hospitalization were similar in both groups. The hazard ratios for death in higher spKt/V quartile was not associated with lower mortality, p = 0.70. The four significant predictors for death were serum albumin, HR = 2.6, current smoking, HR = 19.3, age, HR = 1.1, and the Index of Coexistent Disease [ICED], HR = 1.9. Conclusion: The effect of spKt/V on short-term mortality was not obvious in twice-weekly dialysis patients. Attention should be paid to patients who smoke, have hypoalbuminemia, are elderly, or have a high ICED.